BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29893840)

  • 1. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey.
    Dan GA; Iliodromitis K; Scherr D; Marín F; Lenarczyk R; Estner HL; Kostkiewicz M; Dagres N; Lip GYH
    Europace; 2018 Aug; 20(8):1382-1387. PubMed ID: 29893840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
    Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
    Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
    Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).
    Barnett AS; Kim S; Fonarow GC; Thomas LE; Reiffel JA; Allen LA; Freeman JV; Naccarelli G; Mahaffey KW; Go AS; Kowey PR; Ansell JE; Gersh BJ; Hylek EM; Peterson ED; Piccini JP
    Circ Arrhythm Electrophysiol; 2017 Nov; 10(11):. PubMed ID: 29141842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate use of anti-thrombotic therapy in patients with atrial fibrillation at single-center experience, Northwest Ethiopia.
    Endewunet E; Tadesse A; Adane A; Abdulkadir M
    BMC Cardiovasc Disord; 2020 Aug; 20(1):375. PubMed ID: 32807083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey.
    Chen J; Lenarczyk R; Boveda S; Richard Tilz R; Hernandez-Madrid A; Ptaszynski P; Pudulis J; Dagres N;
    Europace; 2017 Feb; 19(2):303-307. PubMed ID: 28165525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.
    Proietti M; Nobili A; Raparelli V; Napoleone L; Mannucci PM; Lip GY;
    Clin Res Cardiol; 2016 Nov; 105(11):912-920. PubMed ID: 27245329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment.
    Heidbuchel H; Dagres N; Antz M; Kuck KH; Lazure P; Murray S; Carrera C; Hindricks G; Vahanian A
    Europace; 2018 Dec; 20(12):1919-1928. PubMed ID: 29538637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in referral, procedures, and outcome after ablation for atrial fibrillation in Europe: a report from the Atrial Fibrillation Ablation Pilot Registry of the European Society of Cardiology.
    Riahi S; Arbelo E; Brugada J; Maggioni AP; Tavazzi L; Vardas P; Laroche C; Efremidis M; Xhaet O; Woźniak A; Van Gelder IC; Hjortshoj S
    Europace; 2016 Feb; 18(2):191-200. PubMed ID: 26647447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey.
    Boveda S; Lenarczyk R; Haugaa KH; Iliodromitis K; Finlay M; Lane D; Prinzen FW; Dagres N
    Europace; 2018 Mar; 20(3):555-559. PubMed ID: 29360974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey.
    Potpara TS; Pison L; Larsen TB; Estner H; Madrid A; Blomström-Lundqvist C;
    Europace; 2015 Mar; 17(3):468-72. PubMed ID: 25722478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation.
    Purmah Y; Proietti M; Laroche C; Mazurek M; Tahmatzidis D; Boriani G; Novo S; Lip GYH;
    Europace; 2018 Feb; 20(2):243-252. PubMed ID: 28160483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
    Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.
    Gulizia MM; Cemin R; Colivicchi F; De Luca L; Di Lenarda A; Boriani G; Di Pasquale G; Nardi F; Scherillo M; Lucci D; Fabbri G; Maggioni AP;
    Europace; 2019 Feb; 21(2):230-238. PubMed ID: 30060174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.